The global Silodosin market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Silodosin is a medication that belongs to a class of drugs known as alpha-1 blockers. It is primarily used to treat the symptoms of an enlarged prostate, also known as benign prostatic hyperplasia (BPH). Silodosin works by relaxing the muscles in the prostate and bladder neck, which helps to improve urine flow and reduce symptoms such as difficulty urinating, frequent urination, and weak urine stream. It is available in oral capsule form and is typically taken once daily. Silodosin may also be prescribed for other conditions as determined by a healthcare professional.
This report is a detailed and comprehensive analysis for global Silodosin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Silodosin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Silodosin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Silodosin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Silodosin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Silodosin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Silodosin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Macleods Pharmaceuticals, Lee Pharma (P), Cadila Healthcare, Farmhispania, Jeil Pharmaceutical, Keminntek Laboratories, Msn Laboratories, Alembic Pharma, Aurobindo, Metrochem API, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Silodosin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Powder
Solvent
麻豆原创 segment by Application
Hospital
Clinic
Major players covered
Macleods Pharmaceuticals
Lee Pharma (P)
Cadila Healthcare
Farmhispania
Jeil Pharmaceutical
Keminntek Laboratories
Msn Laboratories
Alembic Pharma
Aurobindo
Metrochem API
Fuji Chemical Industry
Hetero Drugs
KRKA
Precise Chemipharma
Sandoz
Torrent Pharma
Tyche Industries
Kavya pharma
Disha APIs
Cckinase
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Silodosin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Silodosin, with price, sales quantity, revenue, and global market share of Silodosin from 2020 to 2025.
Chapter 3, the Silodosin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Silodosin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Silodosin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Silodosin.
Chapter 14 and 15, to describe Silodosin sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Silodosin Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Powder
1.3.3 Solvent
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Silodosin Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Silodosin 麻豆原创 Size & Forecast
1.5.1 Global Silodosin Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Silodosin Sales Quantity (2020-2031)
1.5.3 Global Silodosin Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Macleods Pharmaceuticals
2.1.1 Macleods Pharmaceuticals Details
2.1.2 Macleods Pharmaceuticals Major Business
2.1.3 Macleods Pharmaceuticals Silodosin Product and Services
2.1.4 Macleods Pharmaceuticals Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Macleods Pharmaceuticals Recent Developments/Updates
2.2 Lee Pharma (P)
2.2.1 Lee Pharma (P) Details
2.2.2 Lee Pharma (P) Major Business
2.2.3 Lee Pharma (P) Silodosin Product and Services
2.2.4 Lee Pharma (P) Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Lee Pharma (P) Recent Developments/Updates
2.3 Cadila Healthcare
2.3.1 Cadila Healthcare Details
2.3.2 Cadila Healthcare Major Business
2.3.3 Cadila Healthcare Silodosin Product and Services
2.3.4 Cadila Healthcare Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Cadila Healthcare Recent Developments/Updates
2.4 Farmhispania
2.4.1 Farmhispania Details
2.4.2 Farmhispania Major Business
2.4.3 Farmhispania Silodosin Product and Services
2.4.4 Farmhispania Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Farmhispania Recent Developments/Updates
2.5 Jeil Pharmaceutical
2.5.1 Jeil Pharmaceutical Details
2.5.2 Jeil Pharmaceutical Major Business
2.5.3 Jeil Pharmaceutical Silodosin Product and Services
2.5.4 Jeil Pharmaceutical Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Jeil Pharmaceutical Recent Developments/Updates
2.6 Keminntek Laboratories
2.6.1 Keminntek Laboratories Details
2.6.2 Keminntek Laboratories Major Business
2.6.3 Keminntek Laboratories Silodosin Product and Services
2.6.4 Keminntek Laboratories Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Keminntek Laboratories Recent Developments/Updates
2.7 Msn Laboratories
2.7.1 Msn Laboratories Details
2.7.2 Msn Laboratories Major Business
2.7.3 Msn Laboratories Silodosin Product and Services
2.7.4 Msn Laboratories Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Msn Laboratories Recent Developments/Updates
2.8 Alembic Pharma
2.8.1 Alembic Pharma Details
2.8.2 Alembic Pharma Major Business
2.8.3 Alembic Pharma Silodosin Product and Services
2.8.4 Alembic Pharma Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Alembic Pharma Recent Developments/Updates
2.9 Aurobindo
2.9.1 Aurobindo Details
2.9.2 Aurobindo Major Business
2.9.3 Aurobindo Silodosin Product and Services
2.9.4 Aurobindo Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Aurobindo Recent Developments/Updates
2.10 Metrochem API
2.10.1 Metrochem API Details
2.10.2 Metrochem API Major Business
2.10.3 Metrochem API Silodosin Product and Services
2.10.4 Metrochem API Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Metrochem API Recent Developments/Updates
2.11 Fuji Chemical Industry
2.11.1 Fuji Chemical Industry Details
2.11.2 Fuji Chemical Industry Major Business
2.11.3 Fuji Chemical Industry Silodosin Product and Services
2.11.4 Fuji Chemical Industry Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Fuji Chemical Industry Recent Developments/Updates
2.12 Hetero Drugs
2.12.1 Hetero Drugs Details
2.12.2 Hetero Drugs Major Business
2.12.3 Hetero Drugs Silodosin Product and Services
2.12.4 Hetero Drugs Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Hetero Drugs Recent Developments/Updates
2.13 KRKA
2.13.1 KRKA Details
2.13.2 KRKA Major Business
2.13.3 KRKA Silodosin Product and Services
2.13.4 KRKA Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 KRKA Recent Developments/Updates
2.14 Precise Chemipharma
2.14.1 Precise Chemipharma Details
2.14.2 Precise Chemipharma Major Business
2.14.3 Precise Chemipharma Silodosin Product and Services
2.14.4 Precise Chemipharma Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Precise Chemipharma Recent Developments/Updates
2.15 Sandoz
2.15.1 Sandoz Details
2.15.2 Sandoz Major Business
2.15.3 Sandoz Silodosin Product and Services
2.15.4 Sandoz Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Sandoz Recent Developments/Updates
2.16 Torrent Pharma
2.16.1 Torrent Pharma Details
2.16.2 Torrent Pharma Major Business
2.16.3 Torrent Pharma Silodosin Product and Services
2.16.4 Torrent Pharma Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Torrent Pharma Recent Developments/Updates
2.17 Tyche Industries
2.17.1 Tyche Industries Details
2.17.2 Tyche Industries Major Business
2.17.3 Tyche Industries Silodosin Product and Services
2.17.4 Tyche Industries Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Tyche Industries Recent Developments/Updates
2.18 Kavya pharma
2.18.1 Kavya pharma Details
2.18.2 Kavya pharma Major Business
2.18.3 Kavya pharma Silodosin Product and Services
2.18.4 Kavya pharma Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Kavya pharma Recent Developments/Updates
2.19 Disha APIs
2.19.1 Disha APIs Details
2.19.2 Disha APIs Major Business
2.19.3 Disha APIs Silodosin Product and Services
2.19.4 Disha APIs Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 Disha APIs Recent Developments/Updates
2.20 Cckinase
2.20.1 Cckinase Details
2.20.2 Cckinase Major Business
2.20.3 Cckinase Silodosin Product and Services
2.20.4 Cckinase Silodosin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 Cckinase Recent Developments/Updates
3 Competitive Environment: Silodosin by Manufacturer
3.1 Global Silodosin Sales Quantity by Manufacturer (2020-2025)
3.2 Global Silodosin Revenue by Manufacturer (2020-2025)
3.3 Global Silodosin Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Silodosin by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Silodosin Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Silodosin Manufacturer 麻豆原创 Share in 2024
3.5 Silodosin 麻豆原创: Overall Company Footprint Analysis
3.5.1 Silodosin 麻豆原创: Region Footprint
3.5.2 Silodosin 麻豆原创: Company Product Type Footprint
3.5.3 Silodosin 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Silodosin 麻豆原创 Size by Region
4.1.1 Global Silodosin Sales Quantity by Region (2020-2031)
4.1.2 Global Silodosin Consumption Value by Region (2020-2031)
4.1.3 Global Silodosin Average Price by Region (2020-2031)
4.2 North America Silodosin Consumption Value (2020-2031)
4.3 Europe Silodosin Consumption Value (2020-2031)
4.4 Asia-Pacific Silodosin Consumption Value (2020-2031)
4.5 South America Silodosin Consumption Value (2020-2031)
4.6 Middle East & Africa Silodosin Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Silodosin Sales Quantity by Type (2020-2031)
5.2 Global Silodosin Consumption Value by Type (2020-2031)
5.3 Global Silodosin Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Silodosin Sales Quantity by Application (2020-2031)
6.2 Global Silodosin Consumption Value by Application (2020-2031)
6.3 Global Silodosin Average Price by Application (2020-2031)
7 North America
7.1 North America Silodosin Sales Quantity by Type (2020-2031)
7.2 North America Silodosin Sales Quantity by Application (2020-2031)
7.3 North America Silodosin 麻豆原创 Size by Country
7.3.1 North America Silodosin Sales Quantity by Country (2020-2031)
7.3.2 North America Silodosin Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Silodosin Sales Quantity by Type (2020-2031)
8.2 Europe Silodosin Sales Quantity by Application (2020-2031)
8.3 Europe Silodosin 麻豆原创 Size by Country
8.3.1 Europe Silodosin Sales Quantity by Country (2020-2031)
8.3.2 Europe Silodosin Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Silodosin Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Silodosin Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Silodosin 麻豆原创 Size by Region
9.3.1 Asia-Pacific Silodosin Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Silodosin Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Silodosin Sales Quantity by Type (2020-2031)
10.2 South America Silodosin Sales Quantity by Application (2020-2031)
10.3 South America Silodosin 麻豆原创 Size by Country
10.3.1 South America Silodosin Sales Quantity by Country (2020-2031)
10.3.2 South America Silodosin Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Silodosin Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Silodosin Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Silodosin 麻豆原创 Size by Country
11.3.1 Middle East & Africa Silodosin Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Silodosin Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Silodosin 麻豆原创 Drivers
12.2 Silodosin 麻豆原创 Restraints
12.3 Silodosin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Silodosin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Silodosin
13.3 Silodosin Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Silodosin Typical Distributors
14.3 Silodosin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Macleods Pharmaceuticals
Lee Pharma (P)
Cadila Healthcare
Farmhispania
Jeil Pharmaceutical
Keminntek Laboratories
Msn Laboratories
Alembic Pharma
Aurobindo
Metrochem API
Fuji Chemical Industry
Hetero Drugs
KRKA
Precise Chemipharma
Sandoz
Torrent Pharma
Tyche Industries
Kavya pharma
Disha APIs
Cckinase
听
听
*If Applicable.
